###begin article-title 0
Ozz-E3 Ubiquitin Ligase Targets Sarcomeric Embryonic Myosin Heavy Chain during Muscle Development
###end article-title 0
###begin p 1
Conceived and designed the experiments: YC AJH AdA. Performed the experiments: YC XQ EZ SM. Analyzed the data: YC XQ EZ SM AB AJH AdA. Contributed reagents/materials/analysis tools: NV. Wrote the paper: YC AB AJH AdA. Principally responsible for the experimental design of this study: AdA. Oversaw all experiments: AdA. Secured funding for the research: AdA. Coordinated the efforts of the authors: AdA.
###end p 1
###begin p 2
Current address: Neuromuscular Section, Associacao de Assistencia a Crianca Deficiente, Sao Paulo, Brazil
###end p 2
###begin p 3
Current address: Instituto de Biociencias, Universidade de Sao Paulo, Sao Paulo, Brazil
###end p 3
###begin p 4
###xml 365 368 365 368 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 362 368 362 368 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ozz<sup>&#8722;/&#8722;</sup></italic>
Muscle contractile proteins are expressed as a series of developmental isoforms that are in constant dynamic remodeling during embryogenesis, but how obsolete molecules are recognized and removed is not known. Ozz is a developmentally regulated protein that functions as the adaptor component of a RING-type ubiquitin ligase complex specific to striated muscle. Ozz-/- mutants exhibit defects in myofibrillogenesis and myofiber differentiation. Here we show that Ozz targets the rod portion of embryonic myosin heavy chain and preferentially recognizes the sarcomeric rather than the soluble pool of myosin. We present evidence that Ozz binding to the embryonic myosin isoform within sarcomeric thick filaments marks it for ubiquitination and proteolytic degradation, allowing its replacement with neonatal or adult isoforms. This unique function positions Ozz within a system that facilitates sarcomeric myosin remodeling during muscle maturation and regeneration. Our findings identify Ozz-E3 as the ubiquitin ligase complex that interacts with and regulates myosin within its fully assembled cytoskeletal structure.
###end p 4
###begin title 5
Introduction
###end title 5
###begin p 6
###xml 646 654 646 654 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 815 818 815 818 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009866-Saad1">[1]</xref>
###xml 1000 1007 1000 1007 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 1007 1010 1007 1010 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009866-Davis1">[2]</xref>
Striated muscle cells exhibit the paradoxical association of a rigidly ordered fine structure with the ability to adapt their size and contractile properties during growth and development, or in response to changes in their patterns of use. Many sarcomeric proteins are developmentally expressed as a series of isoforms leading at maturation to patterns appropriate for slow or fast contraction, and aerobic or anaerobic metabolism. Accordingly, mechanisms must exist to enable replacement of isoforms while maintaining an almost crystalline regularity of structural pattern. The classic suggestion of how such mechanisms may operate is based on in vitro experiments where myosin monomers spontaneously polymerize to reach a dynamic equilibrium between fully polymerized myosin and a small pool of soluble monomers [1]. However, in a theoretical study, Davis concluded that a model based on kinetic parameters could not account for the rapid replacement of one myosin isoform by another that is seen in vivo[2].
###end p 6
###begin p 7
###xml 32 35 32 35 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009866-Hershko1">[3]</xref>
###xml 36 39 36 39 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009866-Schwartz1">[5]</xref>
###xml 274 277 274 277 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009866-Koncarevic1">[6]</xref>
###xml 279 282 279 282 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009866-Sacheck1">[7]</xref>
###xml 489 497 489 497 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 497 500 497 500 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009866-Clarke1">[8]</xref>
###xml 502 505 502 505 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009866-Fielitz1">[9]</xref>
###xml 762 770 762 770 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 841 845 841 845 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009866-Cohen1">[10]</xref>
###xml 979 983 979 983 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009866-Kim1">[11]</xref>
The ubiquitin-proteasome system [3]-[5] is the prime candidate for targeted degradation of most soluble and myofibrillar proteins. In skeletal muscles, ubiquitination of muscle proteins to target them for proteolysis is an important component of cachexia and muscle atrophy [6], [7]. Evidence for ubiquitin-mediated degradation of myosin is mostly indirect, but the E3 ubiquitin ligases MuRF1, which is induced during muscle atrophy, and MuRF3 mediate the ubiquitination of soluble myosin in vitro[8], [9], binding to multiple sites near the head region of MyHC molecules. Ubiquitination by MuRF1 has recently been shown to regulate the disassembly and degradation of the myofibrillar proteins MyBP-C, MLC1, and MLC2; however, MyHC is not ubiquitinated by MuRF1 in vitro when associated in the actomyosin complex or in the intact myofibrils [10]. Interestingly, ubiquitin-dependent degradation has also been indirectly implicated in the regulation of myosin folding and assembly [11].
###end p 7
###begin p 8
###xml 225 229 225 229 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009866-Nastasi1">[12]</xref>
###xml 825 829 825 829 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009866-Nastasi1">[12]</xref>
###xml 986 989 986 989 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009866-Clarke1">[8]</xref>
###xml 991 994 991 994 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009866-Fielitz1">[9]</xref>
###xml 996 1000 996 1000 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009866-Attaix1">[13]</xref>
Ozz, also known as Neurl2 (Neuralized-like protein 2), is the substrate-binding component of a RING (Really Interesting New Gene)-type ubiquitin ligase complex, which comprises Elongin B/C (Elo B/C), Rbx1 and Cullin 5 (Cul5) [12]. The protein primary structure contains two Neuralized Homologous Repeats (NHR1 and NHR2) that serve as protein-protein interaction domains and a SOCS (Suppressor of Cytokine Signaling) box at the C-terminus for recognition by the Elo B/C subcomplex. Ozz expression is muscle-specific and upregulated during muscle fiber differentiation, but we show here that it is downregulated in muscle atrophy. To form an active E3 ligase, Ozz must assemble with the other components of the complex, a process that adds an extra tier to regulation of substrate recognition and ubiquitination by this ligase [12]. This is in contrast to the MuRF family of ubiquitin ligases, which are monomeric and can initiate ubiquitination immediately upon binding their substrates [8], [9], [13].
###end p 8
###begin p 9
###xml 99 102 96 99 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 96 102 93 99 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ozz<sup>&#8722;/&#8722;</sup></italic>
###xml 261 265 255 259 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009866-Nastasi1">[12]</xref>
###xml 103 107 <span type="species:ncbi:10090">mice</span>
We have established that sarcolemmal-associated beta-catenin is a substrate for Ozz-E3 and that ozz-/- mice develop overt sarcomeric defects, which we have attributed in part to the impaired turnover of beta-catenin at the membrane of differentiating myofibers [12].
###end p 9
###begin p 10
###xml 69 72 69 72 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">emb</sub>
###xml 189 192 189 192 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">emb</sub>
###xml 257 261 257 261 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009866-KarschMizrachi1">[14]</xref>
###xml 424 428 424 428 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009866-Bandman1">[15]</xref>
###xml 627 631 627 631 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009866-Kelly1">[16]</xref>
###xml 632 636 632 636 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009866-Duxson1">[18]</xref>
###xml 642 645 642 645 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">emb</sub>
###xml 665 669 665 669 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">slow</sub>
###xml 746 749 746 749 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">neo</sub>
###xml 786 790 786 790 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009866-Harris2">[19]</xref>
###xml 792 796 792 796 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009866-Allen1">[20]</xref>
###xml 902 906 902 906 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009866-dAlbis1">[21]</xref>
###xml 978 982 978 982 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009866-Loughna1">[22]</xref>
###xml 1039 1043 1039 1043 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009866-Wanek1">[23]</xref>
###xml 1113 1117 1113 1117 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009866-Allen1">[20]</xref>
###xml 1119 1123 1119 1123 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009866-Sun1">[24]</xref>
We report here that the sarcomeric embryonic myosin heavy chain (MyHCemb/Myh3) is a novel substrate of Ozz, which specifically recognizes the rod domain or tail region of this protein. MyHCemb expression is associated with initiation of sarcomere formation [14], leading to the idea that it is optimized for self-assembly into new thick filaments followed by a sequence of subunit changes to give rise to adult myofilaments [15]. Embryonic muscles form in two stages: a small number of primary myotubes form a scaffold to direct the later formation of secondary myotubes, which give rise to the majority of adult muscle fibers [16]-[18]. MyHCemb, together with MyHCslow, is expressed during primary myotube formation, and again together with MyHCneo, during secondary myotube formation [19], [20]. It also is the first myosin isoform to be expressed when new myotubes form in regenerating adult muscle [21]; in intact adult muscles during hypertrophy induced by passive stretch [22]; or during recovery from immobilization-induced atrophy [23]. Shortly after birth it is rapidly replaced by adult myosin isoforms [20], [24].
###end p 10
###begin p 11
###xml 103 106 103 106 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">emb</sub>
Here we present evidence that the Ozz-E3 ligase, by binding to the rod domain of a fully assembled MyHCemb, marks it for ubiquitination and degradation, probably facilitating the subsequent assembly of new isoforms. These observations lead to the idea that in muscle tissue the ubiquitin-proteasome system, in addition to its involvement in atrophy, removal of misfolded/damaged proteins, and proper folding and assembly of structural proteins, may also facilitate exchange of isoforms within large polymeric assemblies to regulate tissue development, remodeling and regeneration.
###end p 11
###begin title 12
Results
###end title 12
###begin title 13
Ozz is Downregulated in Muscle Atrophy
###end title 13
###begin p 14
###xml 148 151 148 151 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ozz</italic>
###xml 241 245 241 245 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009866-Nastasi1">[12]</xref>
###xml 247 254 247 254 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0009866-g001">Fig. 1A</xref>
###xml 385 392 385 392 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0009866-g001">Fig. 1B</xref>
###xml 697 701 697 701 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009866-dAlbis1">[21]</xref>
###xml 703 707 703 707 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009866-Couteaux1">[25]</xref>
###xml 827 834 827 834 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0009866-g001">Fig. 1C</xref>
Up-regulation of ubiquitin ligases and protein ubiquitination are common correlates of muscle atrophy. We have shown earlier that the expression of ozz mRNA and Ozz protein increases during muscle development from embryonic day E12.5 onward [12] (Fig. 1A). We now wished to test if there was a similar response with muscle atrophy. Ozz levels progressively fell following denervation (Fig. 1B), suggesting the involvement of Ozz in muscle growth rather than atrophy. The latter conclusion was further supported by the pattern of Ozz expression upon injury of adult muscles with local injection of cardiotoxin. This procedure provokes initial profound muscle degeneration, followed by regeneration [21], [25]. Ozz expression was downregulated during the phase of degeneration, but was upregulated during the regeneration phase (Fig. 1C), confirming that Ozz expression is associated with muscle development and growth.
###end p 14
###begin title 15
Ozz Expression Is Upregulated During Development and Regeneration, but not Atrophy.
###end title 15
###begin p 16
###xml 171 184 171 184 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">gastrocnemius</italic>
###xml 595 598 595 598 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">emb</sub>
###xml 680 683 680 683 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">emb</sub>
###xml 697 700 697 700 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">emb</sub>
###xml 613 618 <span type="species:ncbi:4932">yeast</span>
###xml 755 760 <span type="species:ncbi:4932">yeast</span>
(A) Ozz is present during the initial phase of myogenesis (E12.5) and expression progressively increases during embryonic muscle development. (B) Expression of Ozz in the gastrocnemius muscle progressively decreases during denervation-induced muscle atrophy. (C) Ozz expression following cardiotoxin injection falls during the degeneration phase (2-4d post-injection) and then increases during the regeneration phase (5-10d post-injection) before returning to control levels. (D) Schematic diagram of a myosin molecule, depicting the position of the 3 cDNA clones within the tail portion of MyHCemb isolated by a yeast 2-hybrid screen. (E) To map the Ozz binding region(s) on MyHCemb, various MyHCemb constructs were screened against full length Ozz in a yeast 2-hybrid system. Two reporter genes (HIS3 and LacZ) were employed to assess protein-protein interaction. Amino acid residues are indicated. HMM, heavy meromyosin; LMM, light meromyosin; ACD, adhesion competence domain.
###end p 16
###begin title 17
Ozz Targets Embryonic Myosin Heavy Chain
###end title 17
###begin p 18
###xml 76 79 76 79 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">emb</sub>
###xml 371 374 371 374 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">emb</sub>
###xml 423 430 423 430 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0009866-g001">Fig. 1D</xref>
###xml 482 485 482 485 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">emb</sub>
###xml 781 788 781 788 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0009866-g001">Fig. 1E</xref>
###xml 793 801 793 801 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0009866.s001">Fig. S1A</xref>
###xml 1028 1032 1028 1032 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009866-Sohn1">[26]</xref>
###xml 1401 1408 1401 1408 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0009866-g001">Fig. 1E</xref>
###xml 1413 1421 1413 1421 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0009866.s001">Fig. S1A</xref>
###xml 1760 1763 1760 1763 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">emb</sub>
###xml 1844 1847 1844 1847 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">emb</sub>
###xml 5 10 <span type="species:ncbi:4932">yeast</span>
###xml 39 44 <span type="species:ncbi:10090">mouse</span>
In a yeast 2-hybrid screen of an E14.5 mouse cDNA library we identified MyHCemb as a novel interaction partner of Ozz. Either full-length Ozz or the N-terminal half of the protein (residues 1-229), including the entire NHR1 domain (residues 14-104) and most of the NHR2 domain (residues 208-242) were used as baits. Both screens yielded 3 clones with 93% homology to MyHCemb spanning residues 1042-1941 of the tail domain (Fig. 1D). To confirm Ozz' interaction with the tail of MyHCemb and to identify the minimal regions of the tail needed for this interaction, we performed a series of 2-hybrid experiments using as preys either the full length tail domain (residues 1040-1941), the full length head/neck domain (residues 1-1040), or several deletion mutants of the tail region (Fig. 1E and Fig. S1A). These mutant peptides either included or excluded a 29 amino acids (1873-1901 aa) assembly competence domain (ACD) near the C-terminus of the myosin tail, which is responsible for proper myosin assembly into thick filaments [26]. We found that Ozz interacted strongly with the full-length tail, but not with the head/neck domain. Two deletion fragments of the myosin tail encompassing either the N-terminal amino acids 1041-1535, or the C-terminal amino acids 1536 to 1941 interacted differently with the full length Ozz: the former bound weakly, while the latter maintained a strong interaction (Fig. 1E and Fig. S1A). By further deleting the latter fragment at either its C-terminus (1738-1941 aa) or N-terminus (1536-1871 aa) we completely abolished Ozz binding. Similarly, two truncated fragments spanning amino acids 1872-1941, encompassing the ACD domain, also showed no interaction with Ozz. These results identified at least two regions of the MyHCemb tail crucial for Ozz binding, which likely depends on the 3D folding of the MyHCemb tail.
###end p 18
###begin p 19
###xml 30 33 30 33 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">emb</sub>
###xml 55 63 55 63 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo,</italic>
###xml 267 270 267 270 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">emb</sub>
###xml 441 444 441 444 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">emb</sub>
###xml 510 517 510 517 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0009866-g002">Fig. 2A</xref>
###xml 224 228 <span type="species:ncbi:10090">mice</span>
To verify whether the Ozz-MyHCemb interaction occurred in vivo, crude lysates of proliferating (day 0), differentiating (day 2) and terminally differentiated (day 4) primary myoblast cultures prepared from newborn wild-type mice were immunoprecipitated with anti-MyHCemb antibody or an isotype matching control IgG, and probed on immunoblots with anti-Ozz antibody. The results showed that Ozz was effectively co-immunoprecipitated with MyHCemb, indicating that the two endogenous proteins were firmly linked (Fig. 2A).
###end p 19
###begin title 20
###xml 14 17 14 17 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">emb</sub>
Ozz Binds MyHCemb to Promote its Ubiquitination.
###end title 20
###begin p 21
###xml 170 173 170 173 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">emb</sub>
###xml 322 325 322 325 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">emb</sub>
###xml 380 383 380 383 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">emb</sub>
###xml 419 427 419 427 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">In vitro</italic>
###xml 462 465 462 465 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">emb</sub>
###xml 510 513 510 513 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">emb</sub>
###xml 745 748 733 736 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">emb</sub>
###xml 835 838 823 826 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">emb</sub>
###xml 924 927 912 915 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">emb</sub>
###xml 951 954 939 942 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">emb</sub>
###xml 1006 1009 994 997 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">emb</sub>
###xml 1049 1057 1037 1045 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 1080 1083 1068 1071 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">emb</sub>
###xml 1107 1110 1095 1098 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">emb</sub>
###xml 1191 1199 1179 1187 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">In vitro</italic>
###xml 1276 1279 1264 1267 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">emb</sub>
###xml 1321 1324 1309 1312 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">emb</sub>
###xml 1372 1375 1360 1363 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">emb</sub>
(A) Lysates of undifferentiated cultured myoblasts (day 0) and differentiating or differentiated myotubes (days 2-4) were subjected to immunoprecipitation using anti-MyHCemb, anti-Ozz antibodies, or isotype matching IgG as control. Immunoblotting of the co-precipitated proteins as well as the total lysates with anti-MyHCemb and anti-Ozz antibodies demonstrated that Ozz and MyHCemb are bound in a stable complex. (B) In vitro ubiquitination of recombinant MyHCemb mediated by Ozz-E3 ligase. A GST-tagged MyHCemb fragment of approximately130 kDa (1041-1942 aa), which included the myosin rod region, was incubated with Ozz-E3 ligase and either native ubiquitin or a mutant Ub K48R. In the presence of Ozz-E3 ligase and native ubiquitin the MyHCemb fragment was efficiently ubiquitinated. (Lane 1) Coomassie-stained gel of the GST-MyHCemb fragment used as substrate for the reaction. (Lane 2) Immunoprecipitation of GST-MyHCemb fragment with anti-MyHCemb antibody, followed by immunoblotting with anti-MyHCemb. (Lane 3-6) Immunoprecipitation of the in vitro ubiquitinated GST-MyHCemb fragment with anti-MyHCemb antibody, followed by immunoblotting with anti-GST (3) or anti-Ubiquitin (4-6). In vitro ubiquitination reactions were as follows: (lane 4) Ozz-E3 + ubiquitin - MyHCemb; (lane 3 and 5) Ozz-E3 + ubiquitin + MyHCemb; (lane 6) Ozz-E3 + ubiquitin mutant K48R + MyHCemb.
###end p 21
###begin p 22
###xml 76 79 76 79 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">emb</sub>
###xml 111 119 111 119 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 189 193 189 193 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009866-Nastasi1">[12]</xref>
###xml 215 218 215 218 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">emb</sub>
###xml 361 364 361 364 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">emb</sub>
###xml 460 467 460 467 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0009866-g002">Fig. 2B</xref>
###xml 486 489 486 489 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">emb</sub>
###xml 616 623 616 623 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0009866-g002">Fig. 2B</xref>
###xml 842 849 842 849 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0009866-g002">Fig. 2B</xref>
###xml 912 915 912 915 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">emb</sub>
We next tested if Ozz could exert its ubiquitin ligase activity towards MyHCemb. For this purpose we performed in vitro ubiquitination assays using a purified, reconstituted Ozz-E3 complex [12] and a GST-tagged MyHCemb fragment spanning the tail portion of the protein (residues 1041-1942). The ubiquitinated products were then immunoprecipitated with anti-MyHCemb and the immunoblots probed with anti-ubiquitin antibody or anti-GST antibody, used as control (Fig. 2B). Recombinant MyHCemb tail and its proteolytic fragments of smaller molecular weight were ubiquitinated only in the presence of the Ozz-E3 complex (Fig. 2B, compare lanes 4 and 5). Furthermore, if the assay was performed using the ubiquitin mutant K48R to avoid the formation of a conjugated ubiquitin chain at this residue, ubiquitination was reduced to background levels (Fig. 2B, lane 6), demonstrating that Ozz-E3 polyubiquitinated the MyHCemb tail. Five other GST fusion proteins, used as internal controls, were not ubiquitinated in this assay (data not shown), confirming the specificity of Ozz-E3 activity towards its substrate.
###end p 22
###begin title 23
Ozz Segregates with Fully Assembled Sarcomeric Myosin during Myofibrillogenesis
###end title 23
###begin p 24
###xml 32 36 32 36 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009866-Hoppe1">[27]</xref>
###xml 37 41 37 41 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009866-Du1">[30]</xref>
###xml 256 263 256 263 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 324 327 324 327 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">emb</sub>
###xml 948 951 948 951 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">emb</sub>
###xml 1154 1157 1150 1153 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">emb</sub>
###xml 1226 1229 1222 1225 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">emb</sub>
###xml 1287 1293 1283 1289 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0009866-g003">Fig. 3</xref>
In a chaperone-mediated process [27]-[30] newly synthesized myosin isoforms are serially polymerized as monomers; dimers plus 4 myosin light chains (MLC) to form hexamers; and assembled thick filaments. To determine which pool of myosin is targeted by Ozz in vivo we first tested the chromatographic profiles of Ozz and MyHCemb after gel filtration of muscle extracts from embryos of different stages (E14.5-E18.5). Myosin preparations conventionally employ high ionic strength extraction buffers to solubilize fibrillar myosin. Here we used differential centrifugation of muscle lysates of wild-type embryos in a buffer close to physiological ionic strength to obtain a supernatant containing mostly soluble myosin (S) and an insoluble high-speed pellet including sarcofilamentous myosin (P). Examination of the P myosin preparations with immunofluorescence microscopy confirmed the presence of fragments of sarcomeres staining positively for MyHCemb and alpha-actinin (data not shown), which validated our extraction procedure. We then separated the P and S myosin preparations on gel filtration columns and assessed the levels and distribution of MyHCemb and Ozz on immunoblots of the eluted fractions probed with anti MyHCemb, anti-Ozz and anti-MLC antibodies. The profiles shown in Fig. 3 (upper panels) were generated by densitometric analyses of band intensities.
###end p 24
###begin title 25
###xml 39 42 39 42 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">emb</sub>
Ozz Segregates with Myofilamentous MyHCemb from the Earliest Stages of Myofibrillogenesis.
###end title 25
###begin p 26
###xml 295 298 295 298 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">emb</sub>
###xml 647 650 623 626 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">emb</sub>
###xml 753 756 729 732 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">emb</sub>
Sarcomeric (P) fractions from E14.5 (top), E-16.5 (middle), and E18.5 (bottom) embryonic muscles were separated according to their molecular size (horizontal axis) by gel filtration chromatography. Aliquots of each eluted fraction were separated by SDS-PAGE and then immunoblotted with anti-MyHCemb (green), anti-Ozz (red), and anti-MLC (blue). The average intensities from three experiments were measured and plotted, as indicated. The densitometric analysis of the protein profile shows that the high molecular weight fractions (approximately1500 kDa - approximately900 kDa) of sarcomeric (P) preparations contained polymeric myofilamentous MyHCemb, as confirmed by the presence of MLC. Ozz co-eluted with the high molecular weight myofilamentous MyHCemb only in the sarcomeric (P) fractions, but was conspicuously absent from the cytoplasmic fractions (data not shown). Ozz and MLC also eluted in size fractions corresponding to their monomeric molecular weights, in both sarcomeric and cytoplasmic subcellular fractions (data not shown).
###end p 26
###begin p 27
###xml 233 239 209 215 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0009866-g003">Fig. 3</xref>
###xml 304 307 280 283 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">emb</sub>
###xml 590 593 542 545 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">emb</sub>
###xml 674 680 614 620 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0009866-g003">Fig. 3</xref>
###xml 808 811 748 751 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">emb</sub>
Throughout myofibrillogenesis (E14.5-E18.5) full-length myosin eluted from the column mainly in two groups of fractions in the size ranges approximately1500-900 kDa and approximately800-500 kDa. These fractions from both sarcomeric (Fig. 3) and soluble myosin preparations (data not shown) contained MyHCemb and MLC, indicating the presence of multimeric myosin (approximately1500-900), myosin hexamers (2 heavy chains and 4 light chains, MW 520 kDa), as well as lower mw fragments. A third group of fractions, corresponding to sizes < approximately200 kDa, contained reproducible anti-MyHCemb +ve bands of approximately50 kDa, 30 kDa and 25 kDa, evidently myosin peptides (Fig. 3). Their size distribution indicated that some passed through the column as dimers. The separation pattern of the different MyHCemb bands varied only slightly among embryos of different ages.
###end p 27
###begin p 28
###xml 260 266 260 266 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0009866-g003">Fig. 3</xref>
In the same high molecular weight column fractions of sarcomeric preparations (P), a portion of Ozz consistently co-eluted with filamentous myosin, suggesting that Ozz is already bound to sarcomeric myosin during the early stages of myofibrillogenesis (E14.5, Fig. 3). In contrast, Ozz was totally absent from all fractions in the size range approximately1500-550 kDa from the S preparations (data not shown). Free Ozz eluted from the column in size fragments near its monomeric molecular weight of approximately31 kDa and was detected at comparable levels in both the P and S preparations.
###end p 28
###begin p 29
###xml 74 77 74 77 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">emb</sub>
###xml 291 294 291 294 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">emb</sub>
###xml 307 313 307 313 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0009866-g004">Fig. 4</xref>
###xml 443 446 443 446 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">emb</sub>
###xml 496 509 496 509 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0009866-g004">Fig. 4A and C</xref>
###xml 686 699 686 699 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0009866-g004">Fig. 4B and D</xref>
###xml 799 802 799 802 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">emb</sub>
The finding that Ozz co-elutes with the high molecular weight pool of MyHCemb on size exclusion columns was further supported by immunofluorescence labeling of differentiated primary myotubes (day 4), treated and not treated with the MG-132 proteasome inhibitor, using anti-Ozz and anti-MyHCemb antibodies (Fig. 4). Confocal microscopy and computational analyses of the two fluorescent signals indicated that a selected pool of sarcomeric MyHCemb co-localized with Ozz in the untreated myotubes (Fig. 4A and C). Given that the co-localization of the two proteins increased substantially in fibers treated with the proteasome inhibitor, as determined by the co-localization coefficient (Fig. 4B and D), we can infer that Ozz regulates the proteasomal degradation of a selected pool of sarcomeric MyHCemb during myofiber differentiation.
###end p 29
###begin title 30
###xml 43 46 43 46 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">emb</sub>
Co-localization of Ozz with Sarcomeric MyHCemb during Myofiber Differentiation.
###end title 30
###begin p 31
###xml 212 215 212 215 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">emb</sub>
###xml 535 537 535 537 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">k1</italic>
###xml 542 544 542 544 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">k2</italic>
(A) and (B) Confocal microscopy images of differentiating myotubes (day 4) untreated (A) and treated (B) with MG-132. Cells treated with the proteasome inhibitor showed a clear increase of co-localization of MyHCemb and Ozz compared to untreated myotubes. (C) and (D) Computational analyses of confocal images of differentiated myotubes untreated (C) and treated (D) with MG132 confirmed the visualization of the co-localized fluorochromes. Pearson's correlation coefficient (Rr), Manders overlap (R), and Manders overlap coefficients k1 and k2 were employed to evaluate the extent of colocalization of the two fluorescent dyes.
###end p 31
###begin title 32
Ozz Interacts and Ubiquitinates Fully Assembled Sarcomeric Myosin
###end title 32
###begin p 33
###xml 83 86 83 86 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">emb</sub>
###xml 215 219 215 219 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009866-Trinick1">[31]</xref>
###xml 221 225 221 225 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009866-Kudryashova1">[32]</xref>
###xml 569 576 569 576 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0009866-g005">Fig. 5A</xref>
###xml 816 819 816 819 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">emb</sub>
###xml 878 881 878 881 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">emb</sub>
###xml 1028 1035 1028 1035 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0009866-g005">Fig. 5B</xref>
Having established that a portion of the Ozz protein segregates with assembled MyHCemb, we wanted to ascertain whether Ozz was detectable in a classical preparation of muscle thin-thick filaments from E16.5 embryos [31], [32]. We chose E16.5 embryos because this embryonal stage coincides with the onset of secondary myogenesis. Western blot analysis of these preparations demonstrated the co-purification of Ozz and its direct interacting partner Elo C with the thin-thick filaments, indicating an association of the entire Ozz-E3 complex with fully assembled myosin (Fig. 5A). To further validate these results, we checked whether all components of the Ozz-E3 complex were bound to assembled myosin in the insoluble preparations (P) from muscles of E16.5 embryos. Direct interaction of Ozz with myofilamentous MyHCemb was proven by co-immunoprecipitation of Ozz with anti-MyHCemb antibody only from the insoluble preparations (P), but not from the soluble preparations (S), albeit the amount of Ozz was greater in the latter (Fig. 5B, panels 2 and 6). Together these data show that Ozz is bound in a stable form to assembled sarcomeric myosin since the early stages of myofibrillogenesis, but at an untraceable level to soluble myosin.
###end p 33
###begin title 34
###xml 38 41 38 41 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">emb</sub>
Ozz Interacts with Myofilamentous MyHCemb.
###end title 34
###begin p 35
###xml 561 564 561 564 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">emb</sub>
###xml 640 643 640 643 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">emb</sub>
###xml 702 705 702 705 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">emb</sub>
###xml 947 950 947 950 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">emb</sub>
###xml 1141 1144 1141 1144 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">emb</sub>
###xml 1258 1261 1258 1261 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">emb</sub>
(A) Ozz was recovered in a classical preparation of thin-thick filaments from E16.5 embryonic muscle, demonstrating that it is stably bound to sarcomeric myosin. Also, the presence of Elo C in this preparation indicates that the Ozz-Elo C sub-complex is associated with the myofilaments. (B) Cytoplasmic (S) and sarcomeric (P) fractions from wild-type E16.5 embryonic muscles were analyzed on Western blots for the presence of Ozz and its binding partners Elo B, Elo C, Cul5, Rbx1. The same preparations were also subjected to immunoprecipitation with anti-MyHCemb or anti-Elo C, and the immunoprecipitates blotted and probed with anti-MyHCemb, anti-Ozz or anti-MLC. Ozz co-immunoprecipitated with MyHCemb and Elo C only from the sarcomeric fractions, not the cytoplasmic fractions. (C) In vitro ubiquitination of native sarcofilamentous myosin purified from wild-type newborn muscle (P1). (Lane 1) Ozz-E3 efficiently ubiquitinated sarcomeric MyHCemb. The specificity of the reaction was confirmed by omitting either the substrate (lane 2) or the Ozz-E3 complex (lane 3) from the ubiquitination assay, which significantly reduced the Ub-MyHCemb products. Note the similarity with (B) panel 1, identifying the high molecular weight smear as ubiquitinated MyHCemb.
###end p 35
###begin p 36
###xml 353 360 353 360 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0009866-g005">Fig. 5B</xref>
###xml 488 495 488 495 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0009866-g005">Fig. 5A</xref>
###xml 611 618 611 618 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0009866-g005">Fig. 5B</xref>
###xml 739 742 739 742 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">emb</sub>
###xml 882 885 882 885 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">emb</sub>
###xml 956 959 956 959 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">emb</sub>
###xml 1015 1022 1015 1022 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0009866-g005">Fig. 5B</xref>
###xml 1204 1207 1204 1207 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">emb</sub>
###xml 1453 1456 1453 1456 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">emb</sub>
Fractions from both S and P preparations were also probed on immunoblots with antibodies against each component of the Ozz-E3 complex (Elo B/C, Cul5, and Rbx1). Notably, all 4 proteins were detected together with Ozz not only in the soluble pool (S) of extracted muscle proteins but also in the insoluble sarcomeric preparations from wild-type embryos (Fig. 5B, panels 7-10). Furthermore and in agreement with the observed presence of both Ozz and Elo C in purified thin-thick filaments (Fig. 5A), we found a portion of Ozz bound to Elo C within the myofibrils (P fraction) but not in the soluble (S) fraction (Fig. 5B, panel 4). To ascertain whether the other components of the Ozz-E3 complex associated with the Ozzylated sarcomeric MyHCemb, extracted muscle proteins were immunoprecipitated with anti-Elo C from the S and P fractions and probed on immunoblots with both anti-MyHCemb and antibodies against the remaining E3 components. We found that MyHCemb was effectively co-immunoprecipitated with anti-Elo C (Fig. 5B, panel 5). However, under these stringent experimental conditions (high salt concentration), while we were able to demonstrate Ozz binding with its direct interacting partners, MyHCemb and Elo C, we could not co-immunoprecipitate the remaining components of the Ozz-E3 complex (not shown). Nonetheless, the presence in the sarcomeric, insoluble fractions of all Ozz partners and the demonstrated interaction of Ozz, Elo C and MyHCemb strongly support the notion that the Ozz-E3 complex is assembled within the myofibrils.
###end p 36
###begin p 37
###xml 29 32 29 32 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">emb</sub>
###xml 181 185 181 185 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009866-Pollard1">[33]</xref>
###xml 187 191 187 191 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009866-Margossian1">[34]</xref>
###xml 212 220 212 220 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 320 323 320 323 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">emb</sub>
###xml 325 332 325 332 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0009866-g005">Fig. 5C</xref>
Finally, to test whether MyHCemb was efficiently ubiquitinated by Ozz-E3 when associated with the myofibril, we used sarcofilamentous myosin, purified from wild-type newborn muscle [33], [34], as substrate in an in vitro ubiquitination assay. We found that Ozz-E3 efficiently ubiquitinated the endogenous, assembled MyHCemb (Fig. 5C). The specificity of the reaction was confirmed by the lack of ubiquitinated products in the absence of either the substrate (lane 2) or the Ozz-E3 complex (lane 3).
###end p 37
###begin title 38
###xml 4 7 4 7 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">emb</sub>
###xml 34 37 34 37 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 31 37 31 37 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ozz<sup>&#8722;/&#8722;</sup></italic>
MyHCemb Expression Persists in Ozz-/- Muscle
###end title 38
###begin p 39
###xml 110 113 110 113 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">emb</sub>
###xml 208 216 208 216 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 291 298 291 298 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0009866-g006">Fig. 6A</xref>
###xml 448 451 448 451 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">emb</sub>
###xml 532 545 532 545 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0009866-g006">Fig. 6A and B</xref>
###xml 634 638 634 638 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009866-KarschMizrachi1">[14]</xref>
###xml 640 644 640 644 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009866-Silberstein1">[35]</xref>
###xml 652 655 652 655 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 649 655 649 655 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ozz<sup>&#8722;/&#8722;</sup></italic>
###xml 721 724 721 724 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">emb</sub>
###xml 788 801 788 801 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0009866-g006">Fig. 6A and B</xref>
###xml 919 922 919 922 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 916 922 916 922 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ozz<sup>&#8722;/&#8722;</sup></italic>
###xml 949 963 949 963 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0009866.s002">Fig. S2A and B</xref>
###xml 1026 1029 1026 1029 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">emb</sub>
###xml 1049 1052 1049 1052 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1046 1052 1046 1052 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ozz<sup>&#8722;/&#8722;</sup></italic>
###xml 1094 1102 1094 1102 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0009866.s002">Fig. S2B</xref>
###xml 0 5 <span type="species:ncbi:10090">Mouse</span>
###xml 602 607 <span type="species:ncbi:10090">mouse</span>
###xml 612 617 <span type="species:ncbi:9606">human</span>
Mouse myoblasts in primary culture multiply and then quickly fuse into multinucleated myotubes expressing MyHCemb and other MyHC isoforms. Immunoblots of lysates of primary myoblasts induced to differentiate in vitro confirmed that Ozz expression was rapidly upregulated as myotubes formed (Fig. 6A). Normalization of immuno-positive myosin bands to the Hsp 70 loading control in three independent experiments showed that in wild-type myotubes MyHCemb levels peaked at day 3 and then fell as expression of other isoforms increased (Fig. 6A and B); this pattern of expression has been described in both mouse and human muscle cultures [14], [35]. In ozz-/- myotubes, by contrast, at day 4 and day 5 of differentiation MyHCemb levels remained significantly higher than in control myotubes (Fig. 6A and B). This observation was further confirmed by measuring the mean fluorescence intensity of individual wild-type and ozz-/- primary myotubes (day 4) (Fig. S2A and B). A significant increase in the fluorescence intensity of MyHCemb was detected in ozz-/- myotubes compared to wild-type myotubes (Fig. S2B), suggesting improper regulation of this myosin isoform during myotube formation.
###end p 39
###begin title 40
###xml 4 7 4 7 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">emb</sub>
###xml 49 52 49 52 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 49 52 49 52 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sup>&#8722;/&#8722;</sup></italic>
###xml 46 60 46 60 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ozz<italic><sup>&#8722;/&#8722;</sup></italic>Mutants.</italic>
MyHCemb Expression is Abnormally Prolonged in Ozz-/-Mutants.
###end title 40
###begin p 41
###xml 8 11 8 11 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">emb</sub>
###xml 43 51 43 51 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 74 77 74 77 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 71 77 71 77 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ozz<sup>&#8722;/&#8722;</sup></italic>
###xml 142 145 142 145 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">emb</sub>
###xml 343 346 343 346 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">emb</sub>
###xml 779 782 777 780 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 787 790 785 788 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8211;</sup>
###xml 776 791 774 789 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ozz<sup>+/+</sup>, ozz<sup>+/&#8211;</sup>,</italic>
###xml 799 802 797 800 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 796 802 794 800 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ozz<sup>&#8722;/&#8722;</sup></italic>
###xml 847 850 845 848 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">emb</sub>
###xml 1029 1032 1027 1030 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">emb</sub>
###xml 1225 1228 1223 1226 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">emb</sub>
(A) MyHCemb expression is prolonged during in vitro differentiation of ozz-/- primary myoblasts. Western blots showing the time course of MyHCemb and Ozz expression in undifferentiated myoblasts (day 0) and differentiating or differentiated multinucleated myotubes (day 1-5) from null mutants and wild-type controls. (B) Quantification of MyHCemb expression in the soluble fractions shown in (A), normalized against Hsp 70 levels. Data are expressed as mean +/- SD of three independent experiments. Groups were compared by the Student t-test for two samples assuming equal variance. Mean differences were considered statistically significant when P values were less than 0.05 (*). (C) Western blot analyses of the sarcofilamentous, insoluble fractions of muscle isolated from ozz+/+, ozz+/-, and ozz-/- P7.5 pups showed that the expression of MyHCemb is greater in the null and heterozygous samples than in the wild-type samples. In contrast, in the cytoplasmic, soluble fraction from the same preparations the expression of MyHCemb is greater in the wild-type samples. Ozz expression is approximately halved in heterozygotes, while MLC expression remains normal. GAPDH is shown as loading control. (D) Quantification of MyHCemb expression in the insoluble fractions shown in (C), standardized against GAPDH expression. Data are expressed as mean +/- SD of three independent experiments. Groups were compared by the Student t-test for two samples assuming equal variance. Mean differences were considered statistically significant when P values were less than 0.05 (*).
###end p 41
###begin p 42
###xml 25 28 25 28 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">emb</sub>
###xml 113 117 113 117 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009866-Allen1">[20]</xref>
###xml 148 151 148 151 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">emb</sub>
###xml 189 192 189 192 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 186 192 186 192 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ozz<sup>&#8722;/&#8722;</sup></italic>
###xml 229 232 229 232 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">emb</sub>
###xml 239 242 239 242 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 247 250 247 250 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8211;</sup>
###xml 236 250 236 250 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ozz<sup>&#8722;/&#8722;</sup>, ozz<sup>+/&#8211;</sup></italic>
###xml 258 261 258 261 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 255 261 255 261 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ozz<sup>+/+</sup></italic>
###xml 402 405 402 405 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 399 405 399 405 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ozz<sup>&#8722;/&#8722;</sup></italic>
###xml 473 476 473 476 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">emb</sub>
###xml 558 571 558 571 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0009866-g006">Fig. 6C and D</xref>
###xml 655 658 655 658 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">emb</sub>
###xml 682 685 682 685 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ozz</italic>
###xml 721 728 721 728 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0009866-g006">Fig. 6C</xref>
###xml 822 829 822 829 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0009866-g006">Fig. 6C</xref>
###xml 939 942 939 942 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">emb</sub>
###xml 944 951 944 951 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0009866-g006">Fig. 6C</xref>
###xml 1018 1025 1018 1025 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0009866-g006">Fig. 6C</xref>
###xml 1100 1103 1100 1103 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">emb</sub>
###xml 1149 1152 1149 1152 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1146 1152 1146 1152 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ozz<sup>&#8722;/&#8722;</sup></italic>
###xml 1520 1523 1520 1523 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">emb</sub>
###xml 193 197 <span type="species:ncbi:10090">mice</span>
###xml 309 314 <span type="species:ncbi:10090">mouse</span>
Shortly after birth, MyHCemb expression normally falls rapidly, becoming undetectable within 2-3 weeks postnatal [20]. To test if expression of MyHCemb protein was also disturbed in the ozz-/- mice, we compared the amount of MyHCemb in ozz-/-, ozz+/- and ozz+/+ muscles isolated from the limbs of 7.5-day-old mouse pups. Immunoblots and quantitative analyses of these preparations demonstrated that ozz-/- and heterozygous pups had a significantly higher proportion of MyHCemb in the insoluble myosin fraction than their corresponding wild-type littermates (Fig. 6C and D). By contrast, wild-type soluble myosin had a relatively greater proportion of MyHCemb than the corresponding ozz heterozygous and knockout samples (Fig. 6C, middle panel). A prominent proteolytic fragment of about 50 kDa was similar in all samples (Fig. 6C, middle panel, arrowhead). The levels of MLC in both insoluble and soluble fractions paralleled those of MyHCemb (Fig. 6C, MLC). Total MyHC (antibody MF20) was used as additional control (Fig. 6C). Together these observations denote a phenotype of slowed release of MyHCemb from sarcomeric myofilaments in postnatal ozz-/- muscle tissue. Heterozygotes, which have around half the normal level of expression of Ozz, also had increased levels of insoluble myosin, suggesting that Ozz may be regulatory as well as necessary for normal embryonic myosin isoform disassembly and replacement with the postnatal isoform. One possibility is that an Ozz molecule must attach to each monomer in a MyHCemb dimer to efficiently promote its ubiquitination and removal, making the process sensitive to absolute levels of Ozz expression.
###end p 42
###begin p 43
###xml 170 173 170 173 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 167 173 167 173 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ozz<sup>+/+</sup></italic>
###xml 200 203 200 203 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">emb</sub>
###xml 399 402 399 402 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">emb</sub>
###xml 637 640 637 640 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 634 640 634 640 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ozz<sup>&#8722;/&#8722;</sup></italic>
###xml 680 683 680 683 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">emb</sub>
###xml 854 867 854 867 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">gastrocnemius</italic>
###xml 872 889 872 889 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">tibialis anterior</italic>
###xml 963 966 963 966 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">emb</sub>
###xml 983 990 983 990 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0009866-g007">Fig. 7A</xref>
###xml 1071 1084 1071 1084 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">gastrocnemius</italic>
###xml 1126 1133 1126 1133 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0009866-g007">Fig. 7A</xref>
###xml 1192 1195 1192 1195 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1189 1195 1189 1195 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ozz<sup>&#8722;/&#8722;</sup></italic>
###xml 1233 1236 1233 1236 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">emb</sub>
###xml 1238 1245 1238 1245 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0009866-g007">Fig. 7A</xref>
###xml 1366 1369 1366 1369 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">emb</sub>
###xml 1436 1443 1436 1443 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0009866-g007">Fig. 7B</xref>
These biochemical data were confirmed by immunofluorescence and confocal microscopy analyses of cross sections of the hind limbs from P7.5 wild-type and null pups. In ozz+/+ muscles we found that MyHCemb was in course of being removed and replaced by other MyHC isoforms. In fact, many fibers sectioned near the mid-belly region of individual wild-type muscles showed little or no expression of MyHCemb, which was instead more easily detected in sections near the muscle tendon region of the muscle, indicating a gradient in isoform displacement from the middle towards the ends of the muscle fibers. By contrast, matched sections of ozz-/- limbs displayed a higher number of MyHCemb expressing fibers throughout the length of the muscles, but most prominently near the muscle tendon region. The sections were cut at the level of the distal third of the gastrocnemius and tibialis anterior muscles to include the intra-muscular tendons, and labeled with anti-MyHCemb and phalloidin. Fig. 7A shows a high magnification representative of these sections at the level of the gastrocnemius. Contrary to the wild-type limb muscles (Fig. 7A, lower panels), every fiber close to the tendon in the ozz-/- muscles expressed high levels of MyHCemb (Fig. 7A, upper panels) as did the majority of peripheral fibers of the same muscle. A quantification of the total number of MyHCemb +ve fibers present throughout the length of the limbs is shown in Fig. 7B.
###end p 43
###begin title 44
###xml 28 31 28 31 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">emb</sub>
###xml 48 51 48 51 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 45 51 45 51 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ozz<sup>&#8722;/&#8722;</sup></italic>
###xml 52 56 <span type="species:ncbi:10090">Mice</span>
Prolonged Expression of MyHCemb in Postnatal Ozz-/- Mice.
###end title 44
###begin p 45
###xml 22 25 22 25 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">emb</sub>
###xml 109 112 109 112 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ozz</italic>
###xml 135 149 135 149 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">gastrocnemius,</italic>
###xml 279 282 279 282 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">emb</sub>
###xml 431 434 431 434 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">emb</sub>
(A) Expression of MyHCemb in P7.5 null mutant and wild-type hind limbs. Representative cross sections of the ozz null and wild-type m. gastrocnemius, showing a portion of fibula (Fi) bone and including a portion of the intramuscular distal tendon (T), were stained with anti-MyHCemb and phalloidin. The right panels represent higher magnification pictures of the areas boxed in yellow in the left panels. (B) Quantification of MyHCemb positive fibers in P7.5 null mutant and wild-type muscles. Data are expressed as mean +/- SD of three independent experiments. Groups were compared by the Student t-test for two samples assuming equal variance. Mean differences were considered statistically significant when P values were less than 0.05 (**).
###end p 45
###begin title 46
Discussion
###end title 46
###begin p 47
###xml 200 204 200 204 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009866-Nastasi1">[12]</xref>
###xml 432 435 432 435 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">emb</sub>
###xml 557 565 557 565 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 592 595 592 595 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">emb</sub>
We have previously described the identification of Ozz as the substrate-recognition component of a striated muscle-specific RING-type E3 ubiquitin ligase complex, involved in myofiber differentiation [12]. Here, we present evidence that Ozz plays a critical role in muscle development and regeneration, but not in muscle atrophy. In addition, we found that during muscle differentiation Ozz recognizes the developmental isoform MyHCemb as one of its substrates, marks it for ubiquitination, and is both necessary and sufficient for its ubiquitination in an in vitro assay. Ozz binding to MyHCemb differs from that of other E3 ligases in that it targets the tail portion of assembled sarcomeric myosin rather than the head portion of soluble myosin, and we suggest that these properties are fundamental to its role in muscle development as opposed to muscle atrophy.
###end p 47
###begin p 48
###xml 4 7 4 7 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">emb</sub>
###xml 167 171 167 171 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009866-Allen1">[20]</xref>
###xml 271 275 271 275 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009866-Allen1">[20]</xref>
###xml 356 360 356 360 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009866-Brozanski1">[36]</xref>
###xml 447 450 447 450 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 444 450 444 450 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ozz<sup>&#8722;/&#8722;</sup></italic>
###xml 489 492 489 492 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 486 492 486 492 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ozz<sup>&#8722;/&#8722;</sup></italic>
MyHCemb is the majority myosin isoform in embryonic and neonatal muscle fibers and its expression declines after birth to become undetectable around 3 weeks postnatal [20]. This postnatal decline is a robust process, not affected in null mutants of other myosin isoforms [20] or in animals where development of adult isoforms is retarded by undernutrition [36]. However, we found that the decline is slowed in a model system of differentiating ozz-/- primary myoblasts and in postnatal ozz-/- muscles.
###end p 48
###begin p 49
###xml 269 272 269 272 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009866-Davis1">[2]</xref>
###xml 516 523 516 523 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
During myofibrillogenesis, the developmental exchange of MyHC isoforms requires a myosin molecule to be released from its complex insertion into a sarcomeric thick filament, in order to be replaced by a subsequently expressed isoform. Davis, in a model of this process [2], concluded that core myosin molecules within a myofilament are essentially inaccessible to exchange by mass action and that a "facilitated exchange" process must exist in order to account for the rapid and complete change of isoforms observed in vivo. Without an additional regulatory process, exchange at equilibrium would be limited to the exchange of subunits away from the center of the filament.
###end p 49
###begin p 50
###xml 68 71 68 71 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">emb</sub>
###xml 340 343 340 343 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">emb</sub>
###xml 457 465 457 465 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 505 508 505 508 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">emb</sub>
###xml 586 589 586 589 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">emb</sub>
###xml 650 656 650 656 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0009866-g008">Fig. 8</xref>
###xml 1083 1087 1083 1087 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009866-Landsverk1">[28]</xref>
###xml 1089 1093 1089 1093 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009866-Kachur1">[37]</xref>
We found that Ozz is associated with sarcomeric but not soluble MyHCemb from the earliest stages of muscle formation. The fact that Ozz and its direct partner Elo C could be co-immunoprecipitated from sarcomeric but not soluble myosin extracts of E16.5 embryonic muscle indicates that at this age a proportion of Ozz molecules bound to MyHCemb is assembled into the E3 ligase complex. We also demonstrated that formation of such a complex is sufficient for in vitro ubiquitination of sarcofilamentous MyHCemb. From these findings, we can infer that the orderly removal of assembled MyHCemb is achieved by tagging it with the Ozz-E3 ubiquitin ligase (Fig. 8). This refined mechanism, exchanging single molecules within a macromolecular assembly, would enable isoform exchange without any necessity for demolition and reconstruction within the cell, and is expected to represent a principle, which may be exploited by other subcellular systems. Moreover, our findings complement recent work on myosin assembly, which requires the coordinated action of chaperones and ubiquitin ligases [28], [37] to construct multimeric myosin ready for insertion into sarcomeric thick filaments.
###end p 50
###begin title 51
###xml 61 64 61 64 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">emb</sub>
Model of the Sequence of Events Involved in Ozz-Mediated MyHCemb Degradation from Sarcomeric Thick Filaments.
###end title 51
###begin p 52
###xml 54 57 54 57 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">emb</sub>
###xml 175 179 175 179 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009866-Cohen2">[43]</xref>
###xml 213 216 213 216 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">emb</sub>
###xml 352 355 352 355 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">emb</sub>
###xml 474 477 474 477 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">emb</sub>
###xml 557 560 557 560 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">emb</sub>
###xml 716 719 716 719 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">emb</sub>
(A) Ozz is bound to the rod portion of sarcomeric MyHCemb in the vicinity of residue 1535, a possible region for lateral binding with the ACD residues on adjacent myosin rods [43]. Exchange between sarcomeric MyHCemb and newly synthesized neonatal MyHC may be initiated by full Ozz-E3 ligase assembly and initiation of ubiquitination of sarcomeric MyHCemb, as demonstrated by co-immunoprecipitation of Ozz-Elo C from sarcomeric myosin, and the presence of ubiquitinated MyHCemb in sarcomeric myosin preparations. (B) Isoform exchange, releasing soluble MyHCemb by now having a full Ozz-E3 ligase assembled (C), leading to its prompt ubiquitination and proteolytic cleavage, resulting in the absence of Ozzylated MyHCemb in the soluble myosin pool. (D) Further proteolytic degradation, involving specific proteases and ubiquitination of soluble fragments mediated by monomeric ubiquitin ligases, e.g. MuRF family members.
###end p 52
###begin p 53
###xml 146 150 146 150 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009866-Sohn1">[26]</xref>
###xml 204 207 204 207 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">emb</sub>
###xml 447 450 447 450 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009866-Fielitz1">[9]</xref>
###xml 599 602 599 602 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009866-Fielitz1">[9]</xref>
###xml 604 608 604 608 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009866-Solomon1">[38]</xref>
Myosin assembly into thick filaments depends on a 29 amino acid assembly competence domain (ACD) near the C-terminal end of the myosin rod domain [26]. We found that Ozz recognizes the rod portion of MyHCemb, which forms the core of sarcomeric thick filaments where it is not easily accessed for binding or exchange by soluble cytoplasmic molecules. This is in contrast to the other known myosin E3 ligases, which target the head region of myosin [9], the portion of myosin exposed for interaction with actin and ATP. Furthermore, they appear able to access only sarcoplasmic, not sarcomeric myosin [9], [38], and their E3 ligase activity does not require further activation once they have recognized their substrate.
###end p 53
###begin p 54
###xml 71 74 71 74 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">emb</sub>
###xml 323 326 323 326 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">emb</sub>
###xml 386 389 386 389 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">emb</sub>
###xml 429 436 429 436 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0009866-g003">Fig. 3C</xref>
###xml 436 438 436 438 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">vs</italic>
###xml 440 451 440 451 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0009866-g003">Fig. 3A, 3B</xref>
###xml 582 585 582 585 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">emb</sub>
###xml 587 593 587 593 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0009866-g008">Fig. 8</xref>
We hypothesize that during muscle fiber differentiation sarcomeric MyHCemb becomes ubiquitinated by the Ozz-E3, and dissociates from the rest of the sarcomere. We showed that Ozz and Elo C are present together with sarcomeric myosin from the earliest stages of myofibrillogenesis, but we saw no obvious increase in Ozz/MyHCemb ratio in association with the onset of peak periods of MyHCemb degradation during embryogenesis (e.g. Fig. 3Cvs. Fig. 3A, 3B). On the basis of these results, we conclude that Ozz-E3 ligase promotes the ubiquitination and the degradation of sarcomeric MyHCemb (Fig. 8).
###end p 54
###begin p 55
###xml 698 702 698 702 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009866-Nastasi1">[12]</xref>
However, we cannot exclude that this process may occur in two phases. This alternative model implies that, in contrast with the action of one-chain ligases, Ozz does not immediately initiate ubiquitination and proteolytic degradation but may have a chaperone-like function in a preassembled form and only subsequently may gather the rest of the complex and become an active ligase. This two-step mode of action of the Ozz-E3 may explain the timely and regulated replacement/exchange of myofilamentous myosin during muscle differentiation and regeneration. This model of regulated assembly and disassembly of MyHC could be envisaged also for the adult muscle, where Ozz is expressed at basal levels [12]. In the adult muscle the Ozz-E3 activity would ensure the maintenance of myofiber integrity and the regulated exchange of isoforms under stress fiber conditions.
###end p 55
###begin p 56
###xml 369 373 369 373 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009866-Hoppe1">[27]</xref>
###xml 374 378 374 378 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009866-Du1">[30]</xref>
Modulation of cell structure by disaggregation and reassembly of cytoskeletal subunits is common to all cells, as is ubiquitination of many of the signaling proteins that control this process. The ubiquitin system also regulates signaling proteins controlling cell metabolism, cell cycle, and ion channel turnover, and is involved in chaperone-mediated myosin assembly [27]-[30]. It has a prominent role in recognizing misplaced or damaged proteins and promoting their degradation, and has a particular association with muscle atrophy. However, Ozz is upregulated during development, growth and regeneration, and downregulated in atrophy, and represents to our knowledge the first E3 ligase to be described as having a role in targeting myosin in its fully assembled sarcomeric structure during muscle remodeling. The Ozz model may be a paradigm for other developmental systems requiring protein isoform exchange within complex cytoskeletal structures.
###end p 56
###begin title 57
Materials and Methods
###end title 57
###begin title 58
###xml 0 5 <span type="species:ncbi:4932">Yeast</span>
Yeast Two-Hybrid Screening
###end title 58
###begin p 59
###xml 135 139 135 139 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009866-Nastasi1">[12]</xref>
###xml 192 195 192 195 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">emb</sub>
###xml 287 290 287 290 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">emb</sub>
###xml 417 460 413 456 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-GAGGGTGGGTCGACCATGAGTAGCGACACCGAGATGG-3&#8242;</named-content>
###xml 465 509 461 505 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-TACTTAGCGGCCGCTCATTGTTCGAGGGAGCTCTCCAG-3&#8242;</named-content>
###xml 543 546 539 542 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Sal</italic>
###xml 552 555 548 551 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Not</italic>
###xml 676 679 672 675 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">emb</sub>
###xml 785 788 781 784 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Sal</italic>
###xml 794 797 790 793 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Not</italic>
###xml 22 27 <span type="species:ncbi:10090">mouse</span>
###xml 891 896 <span type="species:ncbi:4932">yeast</span>
###xml 970 975 <span type="species:ncbi:4932">yeast</span>
Screening of an E14.5 mouse cDNA library (gift of P. McKinnon) for putative Ozz-binding partners was performed as previously described [12]. Three cDNA clones encoding the tail portion of MyHCemb were isolated. To confirm the absence of interaction with the head and neck portion of MyHCemb the corresponding prey construct (1-1047 aa) cDNA was amplified using a 10 microl reverse transcription reaction with primers 5'-GAGGGTGGGTCGACCATGAGTAGCGACACCGAGATGG-3' and 5'-TACTTAGCGGCCGCTCATTGTTCGAGGGAGCTCTCCAG-3'. The RT-PCR product was cut with Sal1 and Not1 and inserted into the prey vector pEXP-AD502 in frame with the GAL4 activation domain. The deletion mutants of the MyHCemb tail region were amplified using appropriate primers (see below). These PCR fragments were digested with Sal1 and Not1 and subcloned into the prey vector pEXP-AD502 in frame with the GAL4 activation domain. For yeast two hybrid assays, the bait and prey constructs were co-transformed into yeast strain Mav203. Two reporter genes (HIS3 and LacZ) were employed to study the protein (Invitrogen).
###end p 59
###begin title 60
Primers
###end title 60
###begin p 61
###xml 4 7 4 7 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">emb</sub>
###xml 32 64 32 64 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">GAGGGTGGGTCGACCAAGAAGCTGCGTGTGGA</named-content>
MyHCemb (1042-1535 aa): Forward GAGGGTGGGTCGACCAAGAAGCTGCGTGTGGA
###end p 61
###begin p 62
###xml 14 52 14 52 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">TACTTAGCGGCCGCTCACTCCATCTGTTTTCTGGATTT</named-content>
CCTA; Reverse TACTTAGCGGCCGCTCACTCCATCTGTTTTCTGGATTT.
###end p 62
###begin p 63
###xml 4 7 4 7 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">emb</sub>
###xml 32 64 32 64 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">AGGCTTGTCGACCCTGGAGAAGGCTGACATCC</named-content>
MyHCemb (1536-1941 aa): Forward AGGCTTGTCGACCCTGGAGAAGGCTGACATCC
###end p 63
###begin p 64
###xml 13 50 13 50 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">CGCGTGCGGCCGCTCACTCCTCGCTTTCATGGACCAC</named-content>
AGA; Reverse CGCGTGCGGCCGCTCACTCCTCGCTTTCATGGACCAC.
###end p 64
###begin p 65
###xml 4 7 4 7 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">emb</sub>
###xml 32 64 32 64 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">AGGCTTGTCGACCCTCCAGAGTGAGGTGGAGG</named-content>
MyHCemb (1738-1941 aa): Forward AGGCTTGTCGACCCTCCAGAGTGAGGTGGAGG
###end p 65
###begin p 66
###xml 12 49 12 49 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">CGCGTGCGGCCGCTCACTCCTCGCTTTCATGGACCAC</named-content>
AT; Reverse CGCGTGCGGCCGCTCACTCCTCGCTTTCATGGACCAC.
###end p 66
###begin p 67
###xml 4 7 4 7 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">emb</sub>
###xml 32 65 32 65 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">AGGCTTGTCGACCCTGGAGAAGGCTGACATCCA</named-content>
MyHCemb (1536-1871 aa): Forward AGGCTTGTCGACCCTGGAGAAGGCTGACATCCA
###end p 67
###begin p 68
###xml 12 49 12 49 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">CGCGTGCGGCCGCTCATTTATCCACCAGATCCTGCAA</named-content>
GA; Reverse CGCGTGCGGCCGCTCATTTATCCACCAGATCCTGCAA.
###end p 68
###begin p 69
###xml 4 7 4 7 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">emb</sub>
###xml 32 65 32 65 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">GGCTTGTCGACCCTCCAAGTGAAAGTCAAGTCC</named-content>
MyHCemb (1872-1941 aa): Forward GGCTTGTCGACCCTCCAAGTGAAAGTCAAGTCC;
###end p 69
###begin p 70
###xml 8 45 8 45 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">CGCGTGCGGCCGCTCACTCCTCGCTTTCATGGACCAC</named-content>
Reverse CGCGTGCGGCCGCTCACTCCTCGCTTTCATGGACCAC.
###end p 70
###begin p 71
###xml 4 7 4 7 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">emb</sub>
###xml 32 64 32 64 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">GCTTGTCGACCCAGCATGAGCTAGAGGAGGCC</named-content>
MyHCemb (1901-1941 aa): Forward GCTTGTCGACCCAGCATGAGCTAGAGGAGGCC
###end p 71
###begin p 72
###xml 8 45 8 45 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">CGCGTGCGGCCGCTCACTCCTCGCTTTCATGGACCAC</named-content>
Reverse CGCGTGCGGCCGCTCACTCCTCGCTTTCATGGACCAC.
###end p 72
###begin title 73
Surgical Procedures
###end title 73
###begin p 74
###xml 196 199 196 199 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ozz</italic>
###xml 210 214 210 214 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009866-Nastasi1">[12]</xref>
###xml 640 653 640 653 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">gastrocnemius</italic>
###xml 670 687 666 683 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">tibialis anterior</italic>
###xml 839 840 831 832 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 205 209 <span type="species:ncbi:10090">mice</span>
###xml 725 729 <span type="species:ncbi:10090">mice</span>
###xml 813 817 <span type="species:ncbi:10090">Mice</span>
All animal experiments were performed according to animal protocols approved by our Institutional Animal Care and Use Committee and National Institutes of Health guidelines. C57Bl/6 wild-type and ozz-null mice [12] were anaesthetized with isofluorane, and following surgery received ibuprofen, 7.5 mg/kg daily, for pain relief. Muscles of the lower hind limbs were denervated by sectioning the sciatic nerve in the lower thigh, just above the common peroneal-tibial nerve junction. Alternatively, they were tenotomised by sectioning the Achille's tendon. Muscle degeneration-regeneration was induced by injecting 10 mM cardiotoxin into the gastrocnemius (100 microl) or tibialis anterior (30 microl) muscles of 1-3 month-old mice. All experimental muscles were in the right limbs, with the left used as controls. Mice were sacrificed by CO2 inhalation before dissection.
###end p 74
###begin title 75
Isolation of Embryonic Muscles
###end title 75
###begin p 76
###xml 41 42 41 42 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 15 19 <span type="species:ncbi:10090">mice</span>
Dated pregnant mice were sacrificed by CO2 inhalation, and the uterus quickly removed and placed on ice. Individual embryos were pinned on a Sylgard dish and dissected under ice-cold saline solution. The viscera, skin and spinal cord were removed and the embryo decapitated, leaving muscles of all four limbs, ribcage and back, with their associated cartilage. Tissues were snap frozen in liquid nitrogen.
###end p 76
###begin title 77
Cell Cultures
###end title 77
###begin p 78
###xml 59 63 59 63 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009866-Nastasi1">[12]</xref>
###xml 65 69 65 69 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009866-Hollenbach1">[39]</xref>
###xml 71 75 71 75 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009866-Bois1">[40]</xref>
Myoblast cultures were established as described previously [12], [39], [40].
###end p 78
###begin title 79
Antibodies and Reagents
###end title 79
###begin p 80
###xml 51 55 51 55 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009866-Nastasi1">[12]</xref>
###xml 179 182 179 182 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">emb</sub>
###xml 325 328 325 328 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">emb</sub>
###xml 0 6 <span type="species:ncbi:9986">Rabbit</span>
###xml 142 147 <span type="species:ncbi:10090">Mouse</span>
###xml 414 419 <span type="species:ncbi:10090">mouse</span>
###xml 446 451 <span type="species:ncbi:10090">mouse</span>
###xml 548 554 <span type="species:ncbi:9986">rabbit</span>
###xml 701 706 <span type="species:ncbi:10090">mouse</span>
###xml 785 790 <span type="species:ncbi:10090">mouse</span>
###xml 819 825 <span type="species:ncbi:9986">rabbit</span>
###xml 890 895 <span type="species:ncbi:10090">mouse</span>
Rabbit anti-Ozz antibody was prepared as described [12]. The antibody was diluted 1:500 for Western blotting and 1:10 for immunofluorescence. Mouse monoclonal antibodies anti-MyHCemb (F1.652) 1:400, anti-MLC (T14) 1:500, and anti-pan myosin (MF20) 1:500 were purchased from the Developmental Studies Hybridoma Bank. Anti-MyHCemb (2B6) 1:500, was a gift from Dr. N. Rubinstein. Other commercial antibodies included mouse anti-GST 1:500 (UPSTATE), mouse anti-ubiquitin 1:500 (Zymed), anti-Elo C 1:300 (BD Biosciences), anti-GAPDH 1:5000 (Millipore), rabbit anti-Elo B 1:300 (Santa Cruz), anti-Rbx-1 1:500 (Thermo Scientific), anti-Cul5 1:200 (Santa Cruz), anti-pan actin 1:5000 (Cell Signaling), normal mouse IgG (Santa Cruz), anti-Hsp 70 1:4000 (Novus Biologicals), Cy3-conjugated anti mouse IgG and Cy3-conjugated anti-rabbit 1:500 (Jackson ImmunoResearch), Alexa Fluor 488-conjugated anti-mouse 1:500 (Invitrogen), FITC-Phalloidin 1:500 (SIGMA-ALDRICH) and MG-132 (Enzo Life Sciences).
###end p 80
###begin title 81
Co-immunoprecipitation
###end title 81
###begin p 82
###xml 8 11 8 11 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">emb</sub>
###xml 102 105 102 105 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">emb</sub>
###xml 695 698 685 688 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">emb</sub>
Ozz-MyHCemb complexes were detected in crude lysates of myoblast by immunoprecipitation with anti-MyHCemb antibody, followed by Western blotting of the immunoprecipitates with the anti-Ozz antibody. Cultured myoblasts were lysed (lysis buffer: 50 mM HEPES (pH 7.5), 150 mM NaCl, 1% Igepal CA-630, 0.5% deoxycholate, 0.1% SDS, 5 mM EDTA, 1 mM EGTA, 1 mM DTT, 1 mM PMSF, protease inhibitors, phosphatase inhibitor), incubated at 4degreesC for 30 min, and cellular debris were pelleted by 20 min centrifugation at 12000 x g. The lysate was pre-cleared by 1 hr incubation at room temperature with 30 microl of Gamma Bind Plus Sepharose beads (Amersham Biosciences) and then spun at 1500xg. Anti-MyHCemb (2B6) or anti-Ozz antibody was added to the supernatant and incubated for 1 hr at room temperature, followed by immunoprecipitation with Gamma Bind Plus Sepharose beads and overnight incubation at 4degreesC. The beads were washed 3x with lysis buffer, and 1x with lysis buffer without detergents, and the bound proteins detached and run on SDS-polyacrylamide gels under denaturing conditions.
###end p 82
###begin title 83
Fractionation of Muscle Tissues and Co-immunoprecipitation
###end title 83
###begin p 84
###xml 123 127 123 127 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009866-Landsverk1">[28]</xref>
###xml 172 173 172 173 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
Muscles from E14.5, E16.5, and E18.5 embryos were homogenized for 60s in a Dounce homogenizer in 4 volumes of lysis buffer [28] (Tris-HCl, 20 mM, pH 8.0; NaCl, 200 mM; MgCl2, 5 mM; DTT, 5 mM) and centrifuged at 16000xg for 5 min. The supernatant was then spun at 100,000xg for 2.5 hr at 4degreesC. The resulting supernatant was kept as the S fraction (cytoplasmic) and the pellet as the P fraction (sarcomeric). The P fraction was resuspended in 600 microl of lysis buffer.
###end p 84
###begin p 85
###xml 98 101 98 101 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">emb</sub>
S and P fractions prepared from E16.5 embryos were immunoprecipitated with anti-Elo C or anti-MyHCemb using Protein G Dynabeads (Invitrogen), as described above.
###end p 85
###begin title 86
Gel filtration Columns of S and P Fractions
###end title 86
###begin p 87
S and P fractions were separated on a Superose 6 gel filtration column (GE Healthcare). Aliquots from the gel filtration column were then denatured and run on SDS-polyacrylamide gels, followed by Western blotting with the appropriate antibodies. For calculation of the molecular weight the column was calibrated with the following proteins: thyroglobulin, 669 kDa; apoferritin, 443 kDa; beta-amylase, 200 kDa; carbonic anhydrase, 29 kDa (SIGMA). At least 54 aliquots were analyzed, giving a size resolution from approximately2000 kDa to <10 kDa.
###end p 87
###begin title 88
###xml 35 38 35 38 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">emb</sub>
In vitro Ubiquitination of GST-MyHCemb Fragment
###end title 88
###begin p 89
###xml 47 50 43 46 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">emb</sub>
###xml 383 384 367 368 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
Four microg of a bacterially expressed GST-MyHCemb fragment (1041-1941 aa) was incubated with 150 ng of purified recombinant E1 (Calbiochem), 200 ng UbcH5b (a gift of Dr. B. Schulman), 1.0 microg Ozz-E3 ubiquitin ligase and 7.5 microg of ubiquitin (Calbiochem) or K48R ubiquitin (Calbiochem) in a final volume of 30 microl of ubiquitination buffer (0.05M Tris-HCl, pH 7.6; 0.01M MgCl2, 0.004M ATP) at 30degreesC for 60 min.
###end p 89
###begin p 90
###xml 61 64 57 60 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">emb</sub>
###xml 343 346 335 338 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">emb</sub>
###xml 422 425 414 417 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">emb</sub>
To analyze the ubiquitinated products, 4.0 microg of GST-MyHCemb fragment (used as control) or the ubiquination reaction mixtures were diluted in 500 microl of RIPA buffer (50 mM Tris HCl (pH 7.5), 150 mM NaCl, 1% NP-40, 0.1% deoxycholate, 0.1% SDS, 1 mM EDTA, protease inhibitors and phosphatase inhibitors), immunoprecipitated with anti-MyHCemb (2B6), resolved on a 7.5% SDS-gels, and immunoblotted with either anti-MyHCemb, anti-ubiquitin, or anti-GST antibodies (Zymed).
###end p 90
###begin title 91
###xml 17 25 17 25 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">In Vitro</italic>
Purification and In Vitro Ubiquitination of Native MyHC
###end title 91
###begin p 92
###xml 57 61 57 61 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009866-Pollard1">[33]</xref>
###xml 63 67 63 67 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009866-Margossian1">[34]</xref>
###xml 111 119 107 115 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
Sarcomeric MyHC from P1 muscle was purified as described [33], [34]. Purified MyHC (3 microg) was subjected to in vitro ubiquitination following the conditions described above. The reaction mixtures were resolved on a 7.5% SDS-polyacrylamide gel and immunoblotted with anti-ubiquitin antibody (Zymed).
###end p 92
###begin title 93
Thin-Thick Filaments
###end title 93
###begin p 94
###xml 98 102 98 102 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009866-Trinick1">[31]</xref>
Muscle sarcomeric thin-thick filaments were purified according to the procedure of Trinick et al. [31].
###end p 94
###begin title 95
Western Blotting
###end title 95
###begin p 96
###xml 379 383 <span type="species:ncbi:9925">goat</span>
###xml 389 395 <span type="species:ncbi:9986">rabbit</span>
###xml 404 409 <span type="species:ncbi:10090">mouse</span>
Protein concentrations were determined as OD 595, using BSA as standard. 25 microg of soluble protein or 6.25 microg of insoluble protein were electrophoresed (100 V, 60 min) on SDS- gradient gels (NuPAGE 4-12% Bis-Tris Gel, Invitrogen), and wet-blotted overnight at 30 mA. Membranes were probed with specific antibodies at the dilutions listed above, followed by HRP conjugated goat anti-rabbit or anti-mouse IgG (Jackson ImmunoResearch Laboratories). Signals were detected with a West Femto maximum sensitivity substrate kit (Thermo Scientific) on a molecular imager (ChemiDoc XRS, BioRad). Each of the immunoblots included in the Figures was representative of results obtained in at least three independent experiments.
###end p 96
###begin p 97
Immunoblots were photographed in a BioRad Chemidoc XRS Molecular Imager, and, where appropriate, band densities measured using BioRad Quantity One software. Montages were assembled using Adobe Illustrator, and then converted to TIFF files.
###end p 97
###begin title 98
Immunofluorescence and Imaging
###end title 98
###begin p 99
###xml 298 301 288 291 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">emb</sub>
###xml 486 489 476 479 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">emb</sub>
###xml 323 329 <span type="species:ncbi:9986">rabbit</span>
###xml 382 387 <span type="species:ncbi:10090">mouse</span>
###xml 562 567 <span type="species:ncbi:10090">mouse</span>
Immunofluorescence analyses were performed on cultured myotubes (day 4) treated and not treated with proteasome inhibitor. MG-132 was added to the culture medium at a final concentration of 5 microM for 6 hr at 37degreesC. Myotubes were fixed in 3% PFA and immunostained with anti-Ozz and anti MyHCemb antibodies. Cy3 anti-rabbit IgG (Jackson Laboratories) and Alexa Fluor 488 anti-mouse IgG (Invitrogen) were used as secondary antibodies. Analysis of the fluorescence intensity of MyHCemb was performed on cultured myotubes (day 4). In this experiment Cy3 anti-mouse IgG (Jackson Laboratories) was used as secondary antibody.
###end p 99
###begin p 100
###xml 35 38 35 38 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">emb</sub>
###xml 125 128 125 128 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 122 128 122 128 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ozz<sup>&#8722;/&#8722;</sup></italic>
###xml 322 325 322 325 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">emb</sub>
Immunofluorescence analyses of MyHCemb expression in muscle tissue were performed on hind limb muscles from wild-type and ozz-/- P7.5 pups. Muscles were embedded in OTC freezing solution and sectioned sequentially from the distal tendinous insertion towards the mid belly region. Cross sections were labeled with anti-MyHCemb and FITC-Phalloidin (SIGMA) followed by incubation with Cy3-conjugated secondary antibody (Jackson ImmunoResearch) prior to confocal microscopy imaging.
###end p 100
###begin p 101
Images were acquired on a Nikon C1si confocal microscope, with a Plan Apo 40X, NA 1.3 and/or Plan Apo 60X, NA 1.45 objective (Melville, NY).
###end p 101
###begin title 102
Calculation of Co-localization Coefficients
###end title 102
###begin p 103
###xml 196 198 196 198 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">k1</italic>
###xml 203 205 203 205 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">k2</italic>
###xml 1132 1134 1132 1134 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">k1</italic>
###xml 1140 1141 1140 1141 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</italic>
###xml 1207 1209 1207 1209 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">k1</italic>
###xml 1215 1216 1215 1216 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</italic>
###xml 1407 1411 1407 1411 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009866-Manders1">[41]</xref>
###xml 1413 1417 1413 1417 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009866-Zinchuk1">[42]</xref>
Computational analyses of confocal images were performed with the NES-Elements AR 3.1 (Melville, NY). Pearson's correlation coefficient (Rr), Manders overlap (R), and Manders overlap coefficients k1 and k2 were employed to evaluate the extent of co-localization of the two fluorescent dyes. Pearson's correlation coefficient (Rr) is one of the standard measures in pattern recognition. It is used for describing the correlation of the intensity distributions between channels. It takes into consideration only similarity between shapes while ignoring the intensities of signals. Its values range is between -1.0 and 1.0, where 1.0 indicates no overlap and 1.0 is a complete co-localization. Manders overlap coefficient is a generally accepted measure of co-localization. It indicates an overlap of the signals and thus represents the true degree of co-localization. Values of the R are defined from 0 to 1.0. If an image has an overlap coefficient equal to 0.5, it implies that 50% of both its components overlap with the other part of the image. A value of zero means that there are no any overlapping objects Overlap coefficients k1 and k2 split the value of co-localization into two separate parameters. k1 and k2 coefficients depend on the sum of the products of the intensities of two channels. Thus, they are sensitive to the differences in the intensity of two signals and should be used accordingly [41], [42].
###end p 103
###begin title 104
Statistical Analysis
###end title 104
###begin p 105
Data were expressed as mean +/- SD and evaluated using Student's t-test for comparison with wild-type samples. Mean differences were considered statistically significant when P values were less than 0.05 (*).
###end p 105
###begin title 106
Supporting Information
###end title 106
###begin p 107
###xml 88 91 88 91 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">emb</sub>
###xml 4 9 <span type="species:ncbi:4932">Yeast</span>
(A) Yeast 2-Hybrid Screen Demonstrating that Ozz Interacts with the Tail Portion of MyHCemb (1047-1941 aa) but not the Head and Neck (1-1041 aa).
###end p 107
###begin p 108
(8.67 MB TIF)
###end p 108
###begin p 109
Click here for additional data file.
###end p 109
###begin p 110
###xml 57 60 57 60 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">emb</sub>
###xml 182 185 182 185 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">emb</sub>
(A) Immunofluorescence analyses of the expression of MyHCemb in ozz knock-out and wild-type differentiated myoblast (day 4). (B) Quantification of intensity of the expression of MyHCemb in the differentiated myoblast.
###end p 110
###begin p 111
(5.45 MB TIF)
###end p 111
###begin p 112
Click here for additional data file.
###end p 112
###begin p 113
###xml 348 351 348 351 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">emb</sub>
###xml 484 489 <span type="species:ncbi:10090">mouse</span>
A. d'Azzo dedicates this work to Annamaria Cambiaghi d'Azzo. The authors thank G. Grosveld for useful discussion and suggestions; T. Nastasi, L. Fink and C. Saint Martin for their contributions in the initial phase of this project; B. Schulman and N. Rubinstein for their generous gift of reagents for the ubiquitination reactions and the anti-MyHCemb monoclonal antibody; E. Bonten for help with chromatography and useful discussion; E. Gomero for invaluable help in maintaining the mouse colonies; Samuel Connell and Jennifer Peters of the Cell and Tissue Imaging Shared Resource of SJCRH for help with confocal imaging; Charlette Hill for outstanding secretarial assistance. A. d'Azzo holds an endowed chair in Genetics and Gene Therapy from the Jewelry Charity Fund.
###end p 113
###begin title 114
References
###end title 114
###begin article-title 115
Dynamic exchange of myosin molecules between thick filaments.
###end article-title 115
###begin article-title 116
Myosin thick filaments and subunit exchange: a stochastic simulation based on the kinetics of assembly.
###end article-title 116
###begin article-title 117
The ubiquitin system for protein degradation.
###end article-title 117
###begin article-title 118
The ubiquitin-proteasome proteolytic pathway.
###end article-title 118
###begin article-title 119
###xml 77 82 <span type="species:ncbi:9606">human</span>
Targeting proteins for destruction by the ubiquitin system: implications for human pathobiology.
###end article-title 119
###begin article-title 120
The ubiquitin-protein ligase Nedd4 targets Notch1 in skeletal muscle and distinguishes the subset of atrophies caused by reduced muscle tension.
###end article-title 120
###begin article-title 121
Rapid disuse and denervation atrophy involve transcriptional changes similar to those of muscle wasting during systemic diseases.
###end article-title 121
###begin article-title 122
The E3 Ligase MuRF1 degrades myosin heavy chain protein in dexamethasone-treated skeletal muscle.
###end article-title 122
###begin article-title 123
Myosin accumulation and striated muscle myopathy result from the loss of muscle RING finger 1 and 3.
###end article-title 123
###begin article-title 124
During muscle atrophy, thick, but not thin, filament components are degraded by MuRF1-dependent ubiquitylation.
###end article-title 124
###begin article-title 125
Protein quality control gets muscle into shape.
###end article-title 125
###begin article-title 126
Ozz-E3, a muscle-specific ubiquitin ligase, regulates beta-catenin degradation during myogenesis.
###end article-title 126
###begin article-title 127
The ubiquitin-proteasome system and skeletal muscle wasting.
###end article-title 127
###begin article-title 128
###xml 42 47 <span type="species:ncbi:9606">human</span>
Expression and DNA sequence analysis of a human embryonic skeletal muscle myosin heavy chain gene.
###end article-title 128
###begin article-title 129
Contractile protein isoforms in muscle development.
###end article-title 129
###begin article-title 130
###xml 20 23 <span type="species:ncbi:10116">rat</span>
The histogenesis of rat intercostal muscle.
###end article-title 130
###begin article-title 131
###xml 36 39 <span type="species:ncbi:10116">rat</span>
Embryonic growth and innervation of rat skeletal muscles. I. Neural regulation of muscle fibre numbers.
###end article-title 131
###begin article-title 132
The origin of secondary myotubes in mammalian skeletal muscles: ultrastructural studies.
###end article-title 132
###begin article-title 133
Neural control of the sequence of expression of myosin heavy chain isoforms in foetal mammalian muscles.
###end article-title 133
###begin article-title 134
###xml 58 62 <span type="species:ncbi:10090">mice</span>
###xml 67 71 <span type="species:ncbi:10090">mice</span>
Postnatal myosin heavy chain isoform expression in normal mice and mice null for IIb or IId myosin heavy chains.
###end article-title 134
###begin article-title 135
Regeneration after cardiotoxin injury of innervated and denervated slow and fast muscles of mammals. Myosin isoform analysis.
###end article-title 135
###begin article-title 136
Disuse and passive stretch cause rapid alterations in expression of developmental and adult contractile protein genes in skeletal muscle.
###end article-title 136
###begin article-title 137
###xml 39 42 <span type="species:ncbi:10116">rat</span>
Activity-induced fiber regeneration in rat soleus muscle.
###end article-title 137
###begin article-title 138
Cluster characterisation and temporal expression of porcine sarcomeric myosin heavy chain genes.
###end article-title 138
###begin article-title 139
Regeneration of muscles after cardiotoxin injury. I. Cytological aspects.
###end article-title 139
###begin article-title 140
A 29 residue region of the sarcomeric myosin rod is necessary for filament formation.
###end article-title 140
###begin article-title 141
###xml 99 109 <span type="species:ncbi:6239">C. elegans</span>
Regulation of the myosin-directed chaperone UNC-45 by a novel E3/E4-multiubiquitylation complex in C. elegans.
###end article-title 141
###begin article-title 142
###xml 79 101 <span type="species:ncbi:6239">Caenorhabditis elegans</span>
The UNC-45 chaperone mediates sarcomere assembly through myosin degradation in Caenorhabditis elegans.
###end article-title 142
###begin article-title 143
###xml 87 96 <span type="species:ncbi:7955">zebrafish</span>
The myosin co-chaperone UNC-45 is required for skeletal and cardiac muscle function in zebrafish.
###end article-title 143
###begin article-title 144
###xml 96 105 <span type="species:ncbi:7955">zebrafish</span>
Heat-shock protein 90alpha1 is required for organized myofibril assembly in skeletal muscles of zebrafish embryos.
###end article-title 144
###begin article-title 145
Preparation of native thick filaments.
###end article-title 145
###begin article-title 146
Trim32 is a ubiquitin ligase mutated in limb girdle muscular dystrophy type 2H that binds to skeletal muscle myosin and ubiquitinates actin.
###end article-title 146
###begin article-title 147
Myosin purification and characterization.
###end article-title 147
###begin article-title 148
###xml 48 54 <span type="species:ncbi:9986">rabbit</span>
Preparation of myosin and its subfragments from rabbit skeletal muscle.
###end article-title 148
###begin article-title 149
Developmental progression of myosin gene expression in cultured muscle cells.
###end article-title 149
###begin article-title 150
###xml 86 89 <span type="species:ncbi:10116">rat</span>
Effects of perinatal undernutrition on elimination of immature myosin isoforms in the rat diaphragm.
###end article-title 150
###begin article-title 151
Myosin Assembly, Maintenance and Degradation in Muscle: Role of the Chaperone UNC-45 in Myosin Thick Filament Dynamics.
###end article-title 151
###begin article-title 152
###xml 110 116 <span type="species:ncbi:9986">rabbit</span>
Importance of the ATP-ubiquitin-proteasome pathway in the degradation of soluble and myofibrillar proteins in rabbit muscle extracts.
###end article-title 152
###begin article-title 153
The EF-hand calcium-binding protein calmyrin inhibits the transcriptional and DNA-binding activity of Pax3.
###end article-title 153
###begin article-title 154
###xml 56 61 <span type="species:ncbi:10090">mouse</span>
FKHR (FOXO1a) is required for myotube fusion of primary mouse myoblasts.
###end article-title 154
###begin article-title 155
Measurement of co-localization of objects in dual-colour confocal images.
###end article-title 155
###begin article-title 156
Quantitative colocalization analysis of multicolor confocal immunofluorescence microscopy images: pushing pixels to explore biological phenomena.
###end article-title 156
###begin article-title 157
A conserved C-terminal assembly region in paramyosin and myosin rods.
###end article-title 157
###begin p 158
###xml 0 21 0 21 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Competing Interests: </bold>
Competing Interests: The authors have declared that no competing interests exist.
###end p 158
###begin p 159
###xml 0 9 0 9 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Funding: </bold>
###xml 234 242 <span type="species:ncbi:9606">Children</span>
Funding: This work was funded by National Institutes of Health grants R01 AR049867, the Cancer Center Support Grant CA021765, the Assisi Foundation of Memphis, and the American Lebanese Syrian Associated Charities (ALSAC) of St. Jude Children's Research Hospital (SJCRH). These funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
###end p 159

